Canada Consults On Real-World Evidence Guidance For HTAs And Regulators
Canada’s health technology appraisal body is seeking feedback on guidance on the use of real-world evidence in decision making.
You may also be interested in...
Canada’s health technology appraisal body, CADTH, has launched a new program that will harness real-world evidence to provide more information and advice on the safety and effectiveness of drugs that are already approved.
The ABPI, which represents the R&D-based pharmaceutical industry in the UK, says the proposed increase in the statutory scheme rebate sends "the worst possible signal" to global investors and boardrooms.
The German pharmaceutical industry is calling for “directional correction” to the way implementation of the EU’s Health Technology Assessment Regulation is being developed.